217 related articles for article (PubMed ID: 11881984)
21. Phospho-serine/threonine phosphatases in rat islets of Langerhans: identification and effect on insulin secretion.
Murphy LI; Jones PM
Mol Cell Endocrinol; 1996 Mar; 117(2):195-202. PubMed ID: 8737380
[TBL] [Abstract][Full Text] [Related]
22. Calyculin A sensitive protein phosphatase is required for Bacillus anthracis lethal toxin induced cytotoxicity.
Kau JH; Lin CG; Huang HH; Hsu HL; Chen KC; Wu YP; Lin HC
Curr Microbiol; 2002 Feb; 44(2):106-11. PubMed ID: 11815854
[TBL] [Abstract][Full Text] [Related]
23. Okadaic acid: the archetypal serine/threonine protein phosphatase inhibitor.
Dounay AB; Forsyth CJ
Curr Med Chem; 2002 Nov; 9(22):1939-80. PubMed ID: 12369865
[TBL] [Abstract][Full Text] [Related]
24. Identification of a 42 kDa protein as a substrate of protein phosphatase 1 in cilia from Paramecium.
Klumpp S; Schultz JE
FEBS Lett; 1991 Aug; 288(1-2):60-4. PubMed ID: 1652480
[TBL] [Abstract][Full Text] [Related]
25. Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.
Cheng A; Balczon R; Zuo Z; Koons JS; Walsh AH; Honkanen RE
Cancer Res; 1998 Aug; 58(16):3611-9. PubMed ID: 9721869
[TBL] [Abstract][Full Text] [Related]
26. Protein phosphatase 2A is the main phosphatase involved in the regulation of protein kinase B in rat adipocytes.
Resjö S; Göransson O; Härndahl L; Zolnierowicz S; Manganiello V; Degerman E
Cell Signal; 2002 Mar; 14(3):231-8. PubMed ID: 11812651
[TBL] [Abstract][Full Text] [Related]
27. A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A.
Gauss CM; Sheppeck JE; Nairn AC; Chamberlin R
Bioorg Med Chem; 1997 Sep; 5(9):1751-73. PubMed ID: 9354231
[TBL] [Abstract][Full Text] [Related]
28. Reversible protein phosphorylation modulates nucleotide excision repair of damaged DNA by human cell extracts.
Ariza RR; Keyse SM; Moggs JG; Wood RD
Nucleic Acids Res; 1996 Feb; 24(3):433-40. PubMed ID: 8602355
[TBL] [Abstract][Full Text] [Related]
29. A new model of the tautomycin-PP1 complex that is not analogous to the corresponding okadaic acid structure.
Colby DA; Liu W; Sheppeck JE; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem Lett; 2003 May; 13(9):1601-5. PubMed ID: 12699764
[TBL] [Abstract][Full Text] [Related]
30. Fundamental role of the fostriecin unsaturated lactone and implications for selective protein phosphatase inhibition.
Buck SB; Hardouin C; Ichikawa S; Soenen DR; Gauss CM; Hwang I; Swingle MR; Bonness KM; Honkanen RE; Boger DL
J Am Chem Soc; 2003 Dec; 125(51):15694-5. PubMed ID: 14677930
[TBL] [Abstract][Full Text] [Related]
31. The effects of protein phosphatase inhibitors on the duration of central sensitization of rat dorsal horn neurons following injection of capsaicin.
Zhang X; Wu J; Fang L; Willis WD
Mol Pain; 2006 Jul; 2():23. PubMed ID: 16846502
[TBL] [Abstract][Full Text] [Related]
32. Protein phosphatase-protein kinase interplay modulates alpha 1b-adrenoceptor phosphorylation: effects of okadaic acid.
Alcántara-Hernández R; Vázquez-Prado J; Gárcia-Sáinz JA
Br J Pharmacol; 2000 Feb; 129(4):724-30. PubMed ID: 10683197
[TBL] [Abstract][Full Text] [Related]
33. Molecular enzymology underlying regulation of protein phosphatase-1 by natural toxins.
Holmes CF; Maynes JT; Perreault KR; Dawson JF; James MN
Curr Med Chem; 2002 Nov; 9(22):1981-9. PubMed ID: 12369866
[TBL] [Abstract][Full Text] [Related]
34. Versatile enantiocontrolled synthesis of (+)-fostriecin.
Esumi T; Okamoto N; Hatakeyama S
Chem Commun (Camb); 2002 Dec; (24):3042-3. PubMed ID: 12536807
[TBL] [Abstract][Full Text] [Related]
35. Crystal structures of protein phosphatase-1 bound to nodularin-R and tautomycin: a novel scaffold for structure-based drug design of serine/threonine phosphatase inhibitors.
Kelker MS; Page R; Peti W
J Mol Biol; 2009 Jan; 385(1):11-21. PubMed ID: 18992256
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.
Takai A; Sasaki K; Nagai H; Mieskes G; Isobe M; Isono K; Yasumoto T
Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):657-65. PubMed ID: 7702557
[TBL] [Abstract][Full Text] [Related]
37. 19-epi-okadaic acid, a novel protein phosphatase inhibitor with enhanced selectivity.
Cruz PG; Daranas AH; Fernández JJ; Norte M
Org Lett; 2007 Aug; 9(16):3045-8. PubMed ID: 17630753
[TBL] [Abstract][Full Text] [Related]
38. The design, synthesis, and biological evaluation of analogues of the serine-threonine protein phosphatase 1 and 2A selective inhibitor microcystin LA: rational modifications imparting PP1 selectivity.
Aggen JB; Humphrey JM; Gauss CM; Huang HB; Nairn AC; Chamberlin AR
Bioorg Med Chem; 1999 Mar; 7(3):543-64. PubMed ID: 10220039
[TBL] [Abstract][Full Text] [Related]
39. Analyzing gene expression with the use of serine/threonine phosphatase inhibitors.
Schönthal AH
Methods Mol Biol; 1998; 93():35-40. PubMed ID: 9664525
[No Abstract] [Full Text] [Related]
40. Inhibitors of protein phosphatases 1 and 2A differentially prevent intrinsic and extrinsic apoptosis pathways.
Chatfield K; Eastman A
Biochem Biophys Res Commun; 2004 Oct; 323(4):1313-20. PubMed ID: 15451440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
